Upexi, Inc.
UPXI- Exchange
- Nasdaq
- Industry
- Finance Services
- SEC CIK
- 0001775194
No open-market purchases or sales by Upexi, Inc. insiders were filed in the last 90 days; 47 institutions reported holding it in 13F filings for Q2 2026, worth $10.2M in total; no superinvestor holds it.
Key figures
- Insider buysOpen market, last 90 days
- 0
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ2 2026, −8 vs. previous quarter
- 47
- 13F valueReported value at the end of Q2 2026
- $10.2M
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Superinvestors holding UPXI, Q2 2026
No superinvestor reported holding UPXI at the end of Q2 2026.
Latest insider trades
Open-market purchases and sales by Upexi, Inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 23, 2025 (view filing) | Dec 23 | Same day | Marshall AllanChief Executive Officer | PPurchase | +50.0K | $1.80 | +$90.0K | +1.3%4.05M after | |
| Dec 17, 2025 (view filing) | Dec 15-16 | 2 days | Marshall AllanChief Executive Officer | PPurchase | +150.0K | $2.07 | +$310.5K | +3.9%4.00M after | 2 lots |
| Nov 21, 2025 (view filing) | Nov 20 | 1 day | Salkind GeneDirector | PPurchase | +50.0K | $2.55 | +$127.5K | +29.6%218.8K after | |
| Nov 18, 2025 (view filing) | Nov 17 | 1 day | Salkind GeneDirector | PPurchase | +100.0K | $2.65 | +$265.0K | +21.3%569.5K after | |
| Nov 18, 2025 (view filing) | Nov 17 | 1 day | Salkind GeneDirector | PPurchase | +100.0K | $2.81 | +$281.0K | +145.5%168.8K after | |
| Jul 30, 2025 (view filing) | Jul 11 | 19 daysLate | Salkind GeneDirector, 10% Owner | PPurchase | +20.2K | $4.94 | +$100.0K | +5.5%385.4K after | |
| Jul 24, 2025 (view filing) | Jul 15-22 | 9 daysLate | Dugan LawrenceDirector | PPurchase | +16.0K | $6.11 | +$97.8K | +15.9%116.4K after | 4 lots |
| Jul 24, 2025 (view filing) | Jul 11 | 13 daysLate | Marshall AllanChief Executive Officer | PPurchase | +161.9K | $4.94 | +$800.0K | +18.3%1.05M after | |
| Apr 25, 2025 (view filing) | Apr 17 | 8 daysLate | Marshall AllanChief Executive Officer | PPurchase | +657.9K | $2.28 | +$1.50M | +434.5%809.3K after | |
| Apr 25, 2025 (view filing) | Mar 12 | 44 daysLate | Marshall AllanChief Executive Officer | PPurchase | +125.0K | $2.60 | +$325.0K | –125.0K after | Derivative |
Top 10 13F holders, Q2 2026
The largest institutional positions in Upexi, Inc. at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Arrington Capital Management, LLC | 2,760,107 | $2.16M | 2.40% | 00.0% | Unchanged |
| Vanguard Capital Management LLC | 2,409,720 | $1.89M | 0.00% | −972,882−28.8% | Reduced |
| MMCAP International Inc. SPC | 2,326,777 | $1.82M | 0.15% | 00.0% | Unchanged |
| BlackRock, Inc. | 888,906 | $697.1K | 0.00% | +207,598+30.5% | Added |
| Advisor Group Holdings, Inc. | 770,236 | $600.8K | 0.00% | −5,626−0.7% | Reduced |
| Susquehanna International Group, LLP | 703,129 | $551.4K | 0.00% | +4,401+0.6% | Added |
| Geode Capital Management, LLC | 582,895 | $457.4K | 0.00% | +44,378+8.2% | Added |
| Vanguard Fiduciary Trust Co | 311,362 | $244.1K | 0.00% | −16,621−5.1% | Reduced |
| Millennium Management LLC | 271,216 | $212.7K | 0.00% | −22,968−7.8% | Reduced |
| UBS Group AG | 232,206 | $182.0K | 0.00% | −533,570−69.7% | Reduced |